AQUESTIVE THERAPEUTICS INC. - COMMON STOCK
4.8300
13-11月-24 16:45:00
15 分の遅延
株式
-0.1600
-3.21%
本日の幅
4.8150 - 5.1400
ISIN
N/A
ソース
NASDAQ
-
25 4 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
12 4 2024 16:01:00 提供 Nasdaq GlobeNewswire
-
Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive
01 4 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Aquestive Therapeutics Announces Closing of Underwritten Public Offering of Common Stock
25 3 2024 08:00:25 提供 Nasdaq GlobeNewswire
-
Aquestive Therapeutics Announces Pricing of $75 Million Underwritten Public Offering of Common Stock
19 3 2024 21:49:43 提供 Nasdaq GlobeNewswire
-
Aquestive Therapeutics Announces Proposed Public Offering of Common Stock
19 3 2024 16:01:00 提供 Nasdaq GlobeNewswire
-
Aquestive Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
05 3 2024 17:05:49 提供 Nasdaq GlobeNewswire
-
21 2 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
15 2 2024 08:00:35 提供 Nasdaq GlobeNewswire
-
Aquestive Therapeutics to Participate in Oppenheimer 34th Annual Healthcare Conference
30 1 2024 08:00:27 提供 Nasdaq GlobeNewswire
-
05 12 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Aquestive Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
06 11 2023 16:37:36 提供 Nasdaq GlobeNewswire
-
Aquestive Therapeutics Completes $45 Million Debt Refinancing
02 11 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
31 10 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Aquestive Therapeutics Provides Business Update
09 10 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Aquestive Therapeutics Reaffirms Timeline and Pathway for Anaphylm™ (epinephrine) Sublingual Film
20 9 2023 09:04:50 提供 Nasdaq GlobeNewswire
-
Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences
23 8 2023 08:00:42 提供 Nasdaq GlobeNewswire